digital therapeutics
Andy Molnar, CEO of the Digital Therapeutics Alliance, and Scott Stuewe, president and CEO of DirectTrust, discuss their partnership to show digital therapeutics' value and accreditation in healthcare for payors considering DTx coverage.
HIMSS24
Dr. Guido Giunti, Trinity College Dublin's digital therapeutics lead, relays how the institution created a digital therapeutic for multiple sclerosis patients to fight fatigue and his journey to becoming a HIMSS Changemaker award recipient.
HIMSS23
Digital therapeutics improve access to care, but face reimbursement challenges. Jessica Hauflaire, COO of the Digital Therapeutics Alliance, describes the DTA's work with CMS and policymakers to gain support for this new care model.
Armin Scheuer, VP of Business Development International at HIMSS, says Germany is prescribing apps to patients within their normal care setting, in the form of DiGAs, and France has decided to replicate the system.
There needs to be collaboration between the healthcare professional and the patient as opposed to the "carwash model" of healthcare, says Medisafe CMO Dr. Danny Sands.
Liz Ashall-Payne, founder and CEO of ORCHA, says COVID-19 has accelerated the adoption of telehealth, but digital therapeutics, diagnostics and remote patient monitoring will play a more significant role moving forward.
Happify Health's Chris Wasden discusses getting at the root cause rather than just treating symptoms by addressing chronic conditions from a behavior-change perspective.